Can you get Wegovy on the NHS?
Yes—Wegovy (semaglutide) can be prescribed on the NHS, but only for people who meet specific eligibility criteria and within specialist weight-management services rather than routine GP prescribing. Guidance supports use for adults with obesity and a weight-related health condition, typically with a BMI ≥35, or in some cases BMI 30–34.9 if they meet criteria for referral to specialist services; lower BMI thresholds apply for some minority ethnic groups. Access is via referral to an NHS specialist (Tier 3/4) weight-management service, where Wegovy is offered as part of a programme that includes diet, physical activity, and behavioural support. Local NHS areas may apply additional restrictions and phased roll-out, so processes can vary regionally within England.
- Wegovy is available on the NHS under approved criteria, delivered through specialist services—not routine GP prescribing.
- Typical eligibility: BMI ≥35 with a weight-related condition, or BMI 30–34.9 if meeting specialist referral criteria; lower thresholds for some ethnic groups.
- Referral to a Tier 3/4 NHS weight-management service is usually required to access treatment.
- Treatment must be combined with diet, activity, and behavioural support as part of a structured programme.
- Local NHS policies may limit or prioritise access while pathways are finalised or capacity is constrained.
Sources
- NHS England – Medicines for obesity: weight-management injections
- UK Government (DHSC) – Accessing Wegovy for weight loss: everything you need to know
- West Yorkshire HCP – NICE TA875: Semaglutide for obesity (ICS briefing)
- South West London ICB – Wegovy Prescribing Statement (Nov 2024)
- South East London ICS – Interim Policy: Access to Weight-Management Medicines (May 2025)